Newsletter Edition #379 [The Files In-Depth]  Subscribe Now! Readers, Few stories capture global health in all its complexity where science, politics and the economics come together to show the mul...

Just released! Health Justice Initiative’s Explainer on NHI Legal Cases (2023–2026) As South Africa debates the future of universal health coverage, litigation around the NHI Act will shape the policy...

Activists React to Merck’s Voluntary License for Generic Production of Investigational Long-Acting Oral PrEP Product, Alimatravir  If Alimatravir is Approved, Merck’s Unethical Exclusion of Middle Inc...

With the recruitment process ongoing for Unitaid's next Executive Director, the market-shaping agency faces acute financial contraction and growing questions over its opaque selection process compared...

New research also shows that children and high-risk adult populations have been particularly affected.

Lenacapavir promised to change the course of the epidemic, but a limited, geographically selective rollout exposes a harder reality: who gets protected, who is left behind, and whether this is progres...

Lenacapavir promised to change the course of the epidemic, but a limited, geographically selective rollout exposes a harder reality: who gets protected, who is left behind, and whether this is progres...

Secretary of State Marco Rubio called it an opportunity to use the U.N. system to “promote America First values,” according to a cable reviewed by The Post.

PRESS RELEASEFor Immediate Release: April 15, 2026Contact: Asia Russell, Health GAP: (267) 475 2645 | asia@healthgap.org AIDS Activists and Former USAID Employees Arrested Disrupting OMB Secretary Vou...

Africa Health 20 is an annual editorial project highlighting 20 leaders shaping health across Africa.

Blocking humanitarian organizations from accessing a medical breakthrough puts vulnerable people across the world in danger.

MSF calls on Gilead for direct access to lenacapavir, as the current rollout falls far short of the needs.

The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of lenacapavir.

Months into a supposed ceasefire in Gaza, doctors still have to smuggle in basic medical supplies—and treat new casualties of war.

COVID-19 vaccine distribution was marked by deeply unequal access for Africa, Asia, and Latin America. This article analyzes negotiations between government and pharmaceutical companies, through the c...

A new HIV prevention jab has the potential to bring an end to the AIDS epidemic. But a lack of ambition and unjustifiable secrecy over pricing is holding it back, argue three leading health activists.

Matthew Herder and colleagues call for broader mobilisation to avoid the deaths and morbidity in low and middle income countries likely to result from recent US policy changes Announcing the United ...

Matthew Herder and colleagues call for broader mobilisation to avoid the deaths and morbidity in low and middle income countries likely to result from recent US policy changes Announcing the United ...

Matthew Herder and colleagues call for broader mobilisation to avoid the deaths and morbidity in low and middle income countries likely to result from recent US policy changes Announcing the United ...

The researchers argue that U.S. policy shifts are fuelling disease spread and rising deaths—in some countries more than others.

Law and Global Governance of Infectious Disease: Access to Medicines on COVID-19, AIDS, and Beyond

Law and Global Governance of Infectious Disease: Access to Medicines on COVID-19, AIDS, and Beyond